In summary, we demonstrated that elevated H19 expression is a characteristic molecular change in NAFLD, and H19 promotes hepatocyte steatosis, TG secretion and expression of NAFLD-related genes via activating PPARγ signal by sponging miR-130a. The gene discussed is H19; the disease is steatosis.